Glutathione-supported arsenate reduction coupled to arsenolysis catalyzed by ornithine carbamoyl transferase

Toxicology and Applied Pharmacology

Volumn 239, Issue 2, 2009, Pages 154-161

  Németi, Balázs ^a   Gregus, Zoltán ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

N phosphonoacetyl l ornithine; Alamethicin; Arsenate; Arsenic; Arsenite; Arsenolysis; Carbamoyl phosphate; Citrulline; Glutamate; Glutathione; Inosine; Mitochondria; Norvaline; Ornithine; Ornithine carbamoyl transferase; Phosphate; Purine nucleoside phosphorylase; Reduction

Indexed keywords

ARSENIC ACID; ARSENIC TRIOXIDE; CITRULLINE; GLUTATHIONE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOGEN PHOSPHORYLASE; NORVALINE; ORNITHINE CARBAMOYLTRANSFERASE; ORNITHINE DERIVATIVE; PURINE NUCLEOSIDE; PURINE NUCLEOSIDE PHOSPHORYLASE; THIOL;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOSOL; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME PURIFICATION; ENZYME SUBSTRATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INCUBATION TIME; LIVER MITOCHONDRION; MALE; MEMBRANE PERMEABILITY; NONHUMAN; PROTEIN CLEAVAGE; QUANTITATIVE ANALYSIS; RAT; TOXICOKINETICS;

ANIMALS; ARSENATES; ARSENITES; CATALYSIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CITRULLINE; ENVIRONMENTAL POLLUTANTS; GLUTATHIONE; MALE; MITOCHONDRIA, LIVER; ORNITHINE CARBAMOYLTRANSFERASE; OXIDATION-REDUCTION; PURINE-NUCLEOSIDE PHOSPHORYLASE; RATS; RATS, WISTAR; SULFHYDRYL COMPOUNDS;

BACTERIA (MICROORGANISMS); RATTUS;

EID: 67650767084     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.02.011     Document Type: Article

References (35)

1. Cohen P.P., and Marshall M. Carbamyl group transfer. In: Boyer P.D., Lardy H., and Krebs E.G. (Eds). The Enzymes Vol. VI (1962), Academic Press, London 327-338
2. Csanaky I., and Gregus Z. Role of glutathione in reduction of arsenate and of gamma-glutamyltranspeptidase in disposition of arsenite in rats. Toxicology 207 (2005) 91-104
3. Csanaky I., Németi B., and Gregus Z. Dose-dependent biotransformation of arsenite in rats - not S-adenosylmethionine depletion impairs arsenic methylation at high dose. Toxicology 183 (2003) 77-91
4. Dixon H.B.F. The biochemical action of arsonic acids, especially as phosphate analogues. Adv. Inorg. Chem. 44 (1997) 191-227
5. Gamble J.G., and Lehninger A.L. Transport of ornithine and citrulline across the mitochondrial membrane. J. Biol. Chem. 248 (1973) 610-618
6. Goering P.L., Aposhian H.V., Mass M.J., Cebrian M., Beck B.D., and Waalkes M.P. The enigma of arsenic carcinogenesis: role of metabolism. Toxicol. Sci. 49 (1999) 5-14
7. Gornall A.G., Bardawill C.J., and David M.M. Determination of serum proteins by means of the biuret reaction. J. Biol. Chem. 177 (1949) 751-766
8. Gostimskaya I.S., Grivennikova V.G., Zharova T.V., Bakeeva L.E., and Vinogradov A.D. In situ assay of the intramitochondrial enzymes: use of alamethicin for permeabilization of mitochondria. Anal. Biochem. 313 (2003) 46-52
9. Gregus Z., and Németi B. Purine nucleoside phosphorylase as a cytosolic arsenate reductase. Toxicol. Sci. 70 (2002) 13-19
10. Gregus Z., and Németi B. The glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase works as an arsenate reductase in human red blood cells and rat liver cytosol. Toxicol. Sci. 85 (2005) 859-869
11. Gregus Z., and Németi B. Glutathione-dependent reduction of arsenate by glycogen phosphorylase - responsiveness to endogenous and xenobiotic inhibitors. Toxicol. Sci. 100 (2007) 44-53
12. Gregus Z., Fekete T., Halászi E., Gyurasics A., and Klaassen C.D. Effects of fibrates on the glycine conjugation of benzoic acid in rats. Drug Metab. Dispos. 26 (1998) 1082-1088
13. Gregus Z., Gyurasics Á., and Csanaky I. Biliary and urinary excretion of inorganic arsenic: monomethylarsonous acid as a major biliary metabolite in rats. Toxicol. Sci. 56 (2000) 18-25
14. Haag R., and Lewis R.A. The partial purification and characterization of purine nucleoside phosphorylase from mammalian mitochondria. Mol. Cell. Biochem. 135 (1994) 129-136
15. Hughes M.F. Arsenic toxicity and potential mechanisms of action. Toxicol. Lett. 133 (2002) 1-16
16. Hughes M.F. Biomarkers of exposure: a case study with inorganic arsenic. Environ. Health Perspect. 114 (2006) 1790-1796
17. Hughes M.F., Kenyon E.M., and Kitchin K.T. Research approaches to address uncertainties in the risk assessment of arsenic in drinking water. Toxicol. Appl. Pharmacol. 222 (2007) 399-404
18. Indiveri C., Palmieri L., and Palmieri F. Kinetic characterization of the reconstituted ornithine carrier from rat liver mitochondria. Biochim. Biophys. Acta 1188 (1994) 293-301
19. Indiveri C., Tonazzi A., De Palma A., and Palmieri F. Kinetic mechanism of antiports catalyzed by reconstituted ornithine/citrulline carrier from rat liver mitochondria. Biochim. Biophys. Acta 1503 (2001) 303-313
20. Johansson F.I., Michalecka A.M., Møller I.M., and Rasmusson A.G. Oxidation and reduction of pyridine nucleotides in alamethicin-permeabilized plant mitochondria. Biochem. J. 380 (2004) 193-202
21. Kalckar H.M. Differential spectrophotometry of purine compounds by means of specific enzymes: I. Determination of hydroxypurines. J. Biol. Chem. 167 (1947) 429-443
22. Knowles F.C., and Benson A.A. The biochemistry of arsenic. Trends Biochem. Sci. 8 (1983) 178-180
23. Krebs H.A., Eggleston L.V., and Knivett V.A. Arsenolysis and phosphorolysis of citrulline in mammalian liver. Biochem. J. 59 (1955) 185-193
24. Marshall M., and Cohen P.P. Ornithine transcarbamylase from Streptococcus faecalis and bovine liver. II. Multiple binding sites for carbamyl-P and L-norvaline, correlation with steady state kinetics. J. Biol. Chem. 247 (1972) 1654-1668
25. Németi B., and Gregus Z. Mitochondria work as reactors in reducing arsenate to arsenite. Toxicol. Appl. Pharmacol. 182 (2002) 208-218
26. Németi B., and Gregus Z. Glutathione-dependent reduction of arsenate in human erythrocytes - a process independent of purine nucleoside phosphorylase. Toxicol. Sci. 82 (2004) 419-428
27. Németi B., and Gregus Z. Glutathione-dependent reduction of arsenate by glycogen phosphorylase - a reaction coupled to glycogenolysis. Toxicol. Sci. 100 (2007) 36-43
28. Németi B., Csanaky I., and Gregus Z. Arsenate reduction in human erythrocytes and rats - testing the role of purine nucleoside phosphorylase. Toxicol. Sci. 74 (2003) 22-31
29. Pillwein K., Jayaram H.N., and Weber G. Effect of ischemia on nucleosides and bases in rat liver and hepatoma 3924A. Cancer Res. 47 (1987) 3092-3096
30. Radabaugh T.R., Sampayo-Reyes A., Zakharyan R.A., and Aposhian H.V. Arsenate reductase II. Purine nucleoside phosphorylase in the presence of dihydrolipoic acid is a route for reduction of arsenate to arsenite in mammalian systems. Chem. Res. Toxicol. 15 (2002) 692-698
31. Rossman T.G. Mechanism of arsenic carcinogenesis: an integrated approach. Mutat. Res. 533 (2003) 37-65
32. Shi D., Morizono H., Ha Y., Aoyagi M., Tuchman M., and Allewell N.M. 1.85-Å resolution crystal structure of human ornithine transcarbamoylase complexed with N-phosphonacetyl-L-ornithine. Catalytic mechanism and correlation with inherited deficiency. J. Biol. Chem. 273 (1998) 34247-34254
33. Stýblo M., Drobná Z., Jaspers I., Lin S., and Thomas D.J. The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. Environ. Health Perspect. 110 (2002) 767-771
34. Thomas D.J., Stýblo M., and Lin S. The cellular metabolism and systemic toxicity of arsenic. Toxicol. Appl. Pharmacol. 176 (2001) 127-144
35. Tseng C.H. Metabolism of inorganic arsenic and non-cancerous hazards associated with chronic exposure in humans. J. Environ. Biol. 28 (2007) 349-357